PAICON was proud to be part of the 37th European Congress of Pathology (ECP 2025) in Vienna, where leading experts gathered to explore the future of pathology and its transformation through digital and computational innovations.
Showcasing Research in AI-Powered Pathology
Our AI Lead, Dr. Witali Aswolinskiy, presented PAICON’s latest research on how artificial intelligence can enhance biomarker prediction and tissue classification. His posters highlighted two key advances:
-
Predicting microsatellite instability (MSI) in colorectal cancer from routine H&E-stained slides using small sets of highly informative tissue regions.
-
Ultra-fast tissue origin classification to support large-scale digital pathology archives with real-time quality control.
Both projects illustrated how AI can deliver accuracy, efficiency, and interpretability; three pillars that are critical for translating computational pathology into real-world clinical practice.
Why This Matters
As pathology rapidly moves into the digital era, millions of slides are being digitized worldwide. PAICON’s research demonstrates how AI can address the pressing need for scalable, precise, and clinically relevant solutions. By bridging data complexity with actionable insights, our work supports pathologists in making faster and more informed diagnostic decisions.
Looking Forward
ECP 2025 was a valuable opportunity to connect with colleagues, partners, and innovators shaping the future of pathology. We are excited to continue driving progress in AI-powered cancer diagnostics and to further our mission.
